Analyst Reco. Biogen Inc. Xetra

Equities

Market Closed - Xetra Other stock markets 09:05:45 17/05/2024 pm IST			5-day change	1st Jan Change
210.2 ^EUR	-2.37%		+1.79%	-10.48%

16/05	Sector Update: Health Care Stocks Mixed in Late Afternoon Trading	MT
16/05	Sector Update: Health Care Stocks Ease Thursday Afternoon	MT

Argus Raises Biogen's Price Target to $250 From $240	15/05	MT
Redburn Atlantic Adjusts Price Target on Biogen to $235 From $275, Keeps Neutral Rating	08/05	MT
HSBC Adjusts Price Target on Biogen to $342 From $339, Maintains Buy Rating	03/05	MT
Guggenheim Adjusts Price Target on Biogen to $255 From $275	26/04	MT
Goldman Sachs Adjusts Biogen Price Target to $340 From $393	25/04	MT
Canaccord Genuity Adjusts Price Target on Biogen to $308 From $305	25/04	MT
Barclays Adjusts Price Target on Biogen to $200 From $215	25/04	MT
HC Wainwright Adjusts Biogen's Price Target to $300 From $325	25/04	MT
Wedbush Adjusts Price Target on Biogen to $215 From $213	25/04	MT
Morgan Stanley Cuts Biogen's Price Target to $331 From $339	25/04	MT
Piper Sandler Raises Biogen's Price Target to $335 From $325	24/04	MT
RBC Lowers Biogen's Price Target to $317 From $326	24/04	MT
Needham Adjusts Price Target on Biogen to $294 From $300	19/04	MT
BMO Capital Adjusts Price Target on Biogen to $260 From $285, Outperform Rating Kept	19/04	MT
Oppenheimer Adjusts Biogen Price Target to $270 From $290	19/04	MT
UBS Adjusts Biogen's Price Target to $214 From $250, Maintains Neutral Rating	17/04	MT
Wedbush Cuts Biogen's Price Target to $213 From $245	17/04	MT
Argus Adjusts Biogen's Price Target to $240 From $315	15/04	MT
Goldman Sachs Cuts Biogen's Price Target to $393 From $400	15/04	MT
JPMorgan Cuts Biogen's Price Target to $240 From $270, Maintains Neutral Rating	11/04	MT

No results for this search